MedTrace Logo

Phage Safety Cohort Study

NCT04650607 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-04-13

No results posted yet for this study

Summary

This cohort study aims to describe the adverse events related to the use of bacteriophages to treat serious infections, data from the literature being almost non-existent on this subject.

Conditions

  • Prosthetic Joint Infection
  • Severe Infection

Interventions

OTHER

Adverse event after injection of phages

rate and description of adverse event after injection of phages

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-09
Primary Completion
2023-10-09
Completion
2028-05-09

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04650607 on ClinicalTrials.gov